...
首页> 外文期刊>Influenza and other respiratory viruses. >Costs of a clinical pathway with point‐of‐care testing during influenza epidemic in a Dutch hospital
【24h】

Costs of a clinical pathway with point‐of‐care testing during influenza epidemic in a Dutch hospital

机译:荷兰医院流感流行病期间,临床途径的成本

获取原文

摘要

Our study aim was to determine how a new clinical pathway, including PCR-based influenza point-of-care test (POCT), influences the hospitalisation costs of patients suspected of influenza presenting at the emergency department of a Dutch hospital during two consecutive influenza epidemics (2016-2017 and 2017-2018). Compared to mean costs per patient of €3661 in 2016-2017, the implementation of this new clinical pathway with influenza POCT in 2017 was associated with mean costs per influenza-positive patient of €2495 in 2017-2018 (P?=?.3). Our study suggests favourable economic results regarding a new clinical pathway with influenza POCT, reflecting a more efficient care of patients suspected of influenza presenting at the emergency department.? 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
机译:我们的研究目的是确定新的临床途径如何,包括基于PCR的流感护理点测试(POCT),影响涉嫌在两次连续流感流行病的荷兰医院急诊科患者患者的住院费用 (2016-2017和2017-2018)。 与2016 - 2017年€3661€的平均成本相比,2017年在2017年的流感POCT的实施方式与2017 - 2018年€2495€2495的平均成本有关(P?= 3 )。 我们的研究表明有关具有流感POCT的新临床途径的有利经济结果,反映了涉嫌在急诊部门患有流感的患者的更有效护理。 2020作者。 John Wiley&Sons Ltd.出版的流感和其他呼吸病毒

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号